 | • レポートコード：QYR2104Z1552 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、便秘のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（慢性特発性便秘（CIC）、過敏性腸症候群（IBS-C）、オピオイド誘発性便秘（OIC））、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・便秘の市場動向 ・企業の競争状況、市場シェア ・便秘の種類別市場規模（慢性特発性便秘（CIC）、過敏性腸症候群（IBS-C）、オピオイド誘発性便秘（OIC）） ・便秘の用途別市場規模（病院薬局、小売薬局、オンライン薬局） ・便秘の北米市場規模2016-2027（アメリカ、カナダ） ・便秘のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・便秘のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・便秘の中南米市場規模2016-2027（メキシコ、ブラジル） ・便秘の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Takeda Pharmaceutical、Synergy Pharmaceuticals、Sucampo Pharmaceuticals、Ironwood Pharmaceuticals、Bausch Health、Abbott、AstraZeneca、Cosmo Pharmaceuticals、Sanofi、Daewoong Pharmaceuticals、Bayer、Prestige Brands Holdings、Janssen Pharmaceutical、Shionogi、Albireo Pharma、Renexxion） ・結論 |
Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing is termed as constipation. Constipation may be occasional which lasts for few weeks or may be chronic which lasts for longer period and is recurrent. It may be associated with other conditions such as irritable bowel syndrome or opioid consumption.
Based on disease type, the global constipation treatment market is segmented into chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C) and opioid induced constipation (OIC). High prevalence of chronic constipation is estimated to contribute for dominating share of CIC segment in global market while increasing opioid consumption is projected to propel for exponential growth of OIC segment during forecast period.
Market Analysis and Insights: Global Constipation Market
The global Constipation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Constipation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Constipation market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Constipation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Constipation market.
Global Constipation Scope and Market Size
Constipation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Constipation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chronic Idiopathic Constipation (CIC)
Irritable Bowel Syndrome With Constipation (IBS-C)
Opioid-Induced Constipation (OIC)
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Takeda Pharmaceutical
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Bausch Health
Abbott
AstraZeneca
Cosmo Pharmaceuticals
Sanofi
Ironwood Pharmaceuticals
Bausch Health
Prestige Brands Holdings
Janssen Pharmaceutical
Shionogi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Constipation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chronic Idiopathic Constipation (CIC)
1.2.3 Irritable Bowel Syndrome With Constipation (IBS-C)
1.2.4 Opioid-Induced Constipation (OIC)
1.3 Market by Application
1.3.1 Global Constipation Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Constipation Market Perspective (2016-2027)
2.2 Constipation Growth Trends by Regions
2.2.1 Constipation Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Constipation Historic Market Share by Regions (2016-2021)
2.2.3 Constipation Forecasted Market Size by Regions (2022-2027)
2.3 Constipation Industry Dynamic
2.3.1 Constipation Market Trends
2.3.2 Constipation Market Drivers
2.3.3 Constipation Market Challenges
2.3.4 Constipation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Constipation Players by Revenue
3.1.1 Global Top Constipation Players by Revenue (2016-2021)
3.1.2 Global Constipation Revenue Market Share by Players (2016-2021)
3.2 Global Constipation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Constipation Revenue
3.4 Global Constipation Market Concentration Ratio
3.4.1 Global Constipation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Constipation Revenue in 2020
3.5 Constipation Key Players Head office and Area Served
3.6 Key Players Constipation Product Solution and Service
3.7 Date of Enter into Constipation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Constipation Breakdown Data by Type
4.1 Global Constipation Historic Market Size by Type (2016-2021)
4.2 Global Constipation Forecasted Market Size by Type (2022-2027)
5 Constipation Breakdown Data by Application
5.1 Global Constipation Historic Market Size by Application (2016-2021)
5.2 Global Constipation Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Constipation Market Size (2016-2027)
6.2 North America Constipation Market Size by Type
6.2.1 North America Constipation Market Size by Type (2016-2021)
6.2.2 North America Constipation Market Size by Type (2022-2027)
6.2.3 North America Constipation Market Size by Type (2016-2027)
6.3 North America Constipation Market Size by Application
6.3.1 North America Constipation Market Size by Application (2016-2021)
6.3.2 North America Constipation Market Size by Application (2022-2027)
6.3.3 North America Constipation Market Size by Application (2016-2027)
6.4 North America Constipation Market Size by Country
6.4.1 North America Constipation Market Size by Country (2016-2021)
6.4.2 North America Constipation Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Constipation Market Size (2016-2027)
7.2 Europe Constipation Market Size by Type
7.2.1 Europe Constipation Market Size by Type (2016-2021)
7.2.2 Europe Constipation Market Size by Type (2022-2027)
7.2.3 Europe Constipation Market Size by Type (2016-2027)
7.3 Europe Constipation Market Size by Application
7.3.1 Europe Constipation Market Size by Application (2016-2021)
7.3.2 Europe Constipation Market Size by Application (2022-2027)
7.3.3 Europe Constipation Market Size by Application (2016-2027)
7.4 Europe Constipation Market Size by Country
7.4.1 Europe Constipation Market Size by Country (2016-2021)
7.4.2 Europe Constipation Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Constipation Market Size (2016-2027)
8.2 Asia-Pacific Constipation Market Size by Type
8.2.1 Asia-Pacific Constipation Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Constipation Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Constipation Market Size by Type (2016-2027)
8.3 Asia-Pacific Constipation Market Size by Application
8.3.1 Asia-Pacific Constipation Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Constipation Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Constipation Market Size by Application (2016-2027)
8.4 Asia-Pacific Constipation Market Size by Region
8.4.1 Asia-Pacific Constipation Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Constipation Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Constipation Market Size (2016-2027)
9.2 Latin America Constipation Market Size by Type
9.2.1 Latin America Constipation Market Size by Type (2016-2021)
9.2.2 Latin America Constipation Market Size by Type (2022-2027)
9.2.3 Latin America Constipation Market Size by Type (2016-2027)
9.3 Latin America Constipation Market Size by Application
9.3.1 Latin America Constipation Market Size by Application (2016-2021)
9.3.2 Latin America Constipation Market Size by Application (2022-2027)
9.3.3 Latin America Constipation Market Size by Application (2016-2027)
9.4 Latin America Constipation Market Size by Country
9.4.1 Latin America Constipation Market Size by Country (2016-2021)
9.4.2 Latin America Constipation Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Constipation Market Size (2016-2027)
10.2 Middle East & Africa Constipation Market Size by Type
10.2.1 Middle East & Africa Constipation Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Constipation Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Constipation Market Size by Type (2016-2027)
10.3 Middle East & Africa Constipation Market Size by Application
10.3.1 Middle East & Africa Constipation Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Constipation Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Constipation Market Size by Application (2016-2027)
10.4 Middle East & Africa Constipation Market Size by Country
10.4.1 Middle East & Africa Constipation Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Constipation Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Details
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Constipation Introduction
11.1.4 Takeda Pharmaceutical Revenue in Constipation Business (2016-2021)
11.1.5 Takeda Pharmaceutical Recent Development
11.2 Synergy Pharmaceuticals
11.2.1 Synergy Pharmaceuticals Company Details
11.2.2 Synergy Pharmaceuticals Business Overview
11.2.3 Synergy Pharmaceuticals Constipation Introduction
11.2.4 Synergy Pharmaceuticals Revenue in Constipation Business (2016-2021)
11.2.5 Synergy Pharmaceuticals Recent Development
11.3 Sucampo Pharmaceuticals
11.3.1 Sucampo Pharmaceuticals Company Details
11.3.2 Sucampo Pharmaceuticals Business Overview
11.3.3 Sucampo Pharmaceuticals Constipation Introduction
11.3.4 Sucampo Pharmaceuticals Revenue in Constipation Business (2016-2021)
11.3.5 Sucampo Pharmaceuticals Recent Development
11.4 Ironwood Pharmaceuticals
11.4.1 Ironwood Pharmaceuticals Company Details
11.4.2 Ironwood Pharmaceuticals Business Overview
11.4.3 Ironwood Pharmaceuticals Constipation Introduction
11.4.4 Ironwood Pharmaceuticals Revenue in Constipation Business (2016-2021)
11.4.5 Ironwood Pharmaceuticals Recent Development
11.5 Bausch Health
11.5.1 Bausch Health Company Details
11.5.2 Bausch Health Business Overview
11.5.3 Bausch Health Constipation Introduction
11.5.4 Bausch Health Revenue in Constipation Business (2016-2021)
11.5.5 Bausch Health Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Constipation Introduction
11.6.4 Abbott Revenue in Constipation Business (2016-2021)
11.6.5 Abbott Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Constipation Introduction
11.7.4 AstraZeneca Revenue in Constipation Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Cosmo Pharmaceuticals
11.8.1 Cosmo Pharmaceuticals Company Details
11.8.2 Cosmo Pharmaceuticals Business Overview
11.8.3 Cosmo Pharmaceuticals Constipation Introduction
11.8.4 Cosmo Pharmaceuticals Revenue in Constipation Business (2016-2021)
11.8.5 Cosmo Pharmaceuticals Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Constipation Introduction
11.9.4 Sanofi Revenue in Constipation Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 Daewoong Pharmaceuticals
11.10.1 Daewoong Pharmaceuticals Company Details
11.10.2 Daewoong Pharmaceuticals Business Overview
11.10.3 Daewoong Pharmaceuticals Constipation Introduction
11.10.4 Daewoong Pharmaceuticals Revenue in Constipation Business (2016-2021)
11.10.5 Daewoong Pharmaceuticals Recent Development
11.11 Bayer
11.11.1 Bayer Company Details
11.11.2 Bayer Business Overview
11.11.3 Bayer Constipation Introduction
11.11.4 Bayer Revenue in Constipation Business (2016-2021)
11.11.5 Bayer Recent Development
11.12 Prestige Brands Holdings
11.12.1 Prestige Brands Holdings Company Details
11.12.2 Prestige Brands Holdings Business Overview
11.12.3 Prestige Brands Holdings Constipation Introduction
11.12.4 Prestige Brands Holdings Revenue in Constipation Business (2016-2021)
11.12.5 Prestige Brands Holdings Recent Development
11.13 Janssen Pharmaceutical
11.13.1 Janssen Pharmaceutical Company Details
11.13.2 Janssen Pharmaceutical Business Overview
11.13.3 Janssen Pharmaceutical Constipation Introduction
11.13.4 Janssen Pharmaceutical Revenue in Constipation Business (2016-2021)
11.13.5 Janssen Pharmaceutical Recent Development
11.14 Shionogi
11.14.1 Shionogi Company Details
11.14.2 Shionogi Business Overview
11.14.3 Shionogi Constipation Introduction
11.14.4 Shionogi Revenue in Constipation Business (2016-2021)
11.14.5 Shionogi Recent Development
11.15 Albireo Pharma
11.15.1 Albireo Pharma Company Details
11.15.2 Albireo Pharma Business Overview
11.15.3 Albireo Pharma Constipation Introduction
11.15.4 Albireo Pharma Revenue in Constipation Business (2016-2021)
11.15.5 Albireo Pharma Recent Development
11.16 Renexxion
11.16.1 Renexxion Company Details
11.16.2 Renexxion Business Overview
11.16.3 Renexxion Constipation Introduction
11.16.4 Renexxion Revenue in Constipation Business (2016-2021)
11.16.5 Renexxion Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Constipation Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chronic Idiopathic Constipation (CIC)
Table 3. Key Players of Irritable Bowel Syndrome With Constipation (IBS-C)
Table 4. Key Players of Opioid-Induced Constipation (OIC)
Table 5. Global Constipation Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Constipation Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Constipation Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Constipation Market Share by Regions (2016-2021)
Table 9. Global Constipation Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Constipation Market Share by Regions (2022-2027)
Table 11. Constipation Market Trends
Table 12. Constipation Market Drivers
Table 13. Constipation Market Challenges
Table 14. Constipation Market Restraints
Table 15. Global Constipation Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Constipation Market Share by Players (2016-2021)
Table 17. Global Top Constipation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Constipation as of 2020)
Table 18. Ranking of Global Top Constipation Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Constipation Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Constipation Product Solution and Service
Table 22. Date of Enter into Constipation Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Constipation Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Constipation Revenue Market Share by Type (2016-2021)
Table 26. Global Constipation Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Constipation Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Constipation Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Constipation Revenue Market Share by Application (2016-2021)
Table 30. Global Constipation Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Constipation Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Constipation Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Constipation Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Constipation Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Constipation Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Constipation Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Constipation Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Constipation Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Constipation Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Constipation Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Constipation Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Constipation Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Constipation Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Constipation Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Constipation Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Constipation Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Constipation Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Constipation Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Constipation Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Constipation Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Constipation Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Constipation Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Constipation Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Constipation Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Constipation Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Constipation Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Constipation Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Constipation Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Constipation Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Constipation Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Constipation Market Size by Country (2022-2027) & (US$ Million)
Table 62. Takeda Pharmaceutical Company Details
Table 63. Takeda Pharmaceutical Business Overview
Table 64. Takeda Pharmaceutical Constipation Product
Table 65. Takeda Pharmaceutical Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 66. Takeda Pharmaceutical Recent Development
Table 67. Synergy Pharmaceuticals Company Details
Table 68. Synergy Pharmaceuticals Business Overview
Table 69. Synergy Pharmaceuticals Constipation Product
Table 70. Synergy Pharmaceuticals Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 71. Synergy Pharmaceuticals Recent Development
Table 72. Sucampo Pharmaceuticals Company Details
Table 73. Sucampo Pharmaceuticals Business Overview
Table 74. Sucampo Pharmaceuticals Constipation Product
Table 75. Sucampo Pharmaceuticals Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 76. Sucampo Pharmaceuticals Recent Development
Table 77. Ironwood Pharmaceuticals Company Details
Table 78. Ironwood Pharmaceuticals Business Overview
Table 79. Ironwood Pharmaceuticals Constipation Product
Table 80. Ironwood Pharmaceuticals Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 81. Ironwood Pharmaceuticals Recent Development
Table 82. Bausch Health Company Details
Table 83. Bausch Health Business Overview
Table 84. Bausch Health Constipation Product
Table 85. Bausch Health Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 86. Bausch Health Recent Development
Table 87. Abbott Company Details
Table 88. Abbott Business Overview
Table 89. Abbott Constipation Product
Table 90. Abbott Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 91. Abbott Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Constipation Product
Table 95. AstraZeneca Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 96. AstraZeneca Recent Development
Table 97. Cosmo Pharmaceuticals Company Details
Table 98. Cosmo Pharmaceuticals Business Overview
Table 99. Cosmo Pharmaceuticals Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 100. Cosmo Pharmaceuticals Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Constipation Product
Table 104. Sanofi Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 105. Sanofi Recent Development
Table 106. Daewoong Pharmaceuticals Company Details
Table 107. Daewoong Pharmaceuticals Business Overview
Table 108. Daewoong Pharmaceuticals Constipation Product
Table 109. Daewoong Pharmaceuticals Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 110. Daewoong Pharmaceuticals Recent Development
Table 111. Bayer Company Details
Table 112. Bayer Business Overview
Table 113. Bayer Constipation Product
Table 114. Bayer Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 115. Bayer Recent Development
Table 116. Prestige Brands Holdings Company Details
Table 117. Prestige Brands Holdings Business Overview
Table 118. Prestige Brands Holdings Constipation Product
Table 119. Prestige Brands Holdings Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 120. Prestige Brands Holdings Recent Development
Table 121. Janssen Pharmaceutical Company Details
Table 122. Janssen Pharmaceutical Business Overview
Table 123. Janssen Pharmaceutical Constipation Product
Table 124. Janssen Pharmaceutical Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 125. Janssen Pharmaceutical Recent Development
Table 126. Shionogi Company Details
Table 127. Shionogi Business Overview
Table 128. Shionogi Constipation Product
Table 129. Shionogi Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 130. Shionogi Recent Development
Table 131. Albireo Pharma Company Details
Table 132. Albireo Pharma Business Overview
Table 133. Albireo Pharma Constipation Product
Table 134. Albireo Pharma Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 135. Albireo Pharma Recent Development
Table 136. Renexxion Company Details
Table 137. Renexxion Business Overview
Table 138. Renexxion Constipation Product
Table 139. Renexxion Revenue in Constipation Business (2016-2021) & (US$ Million)
Table 140. Renexxion Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Constipation Market Share by Type: 2020 VS 2027
Figure 2. Chronic Idiopathic Constipation (CIC) Features
Figure 3. Irritable Bowel Syndrome With Constipation (IBS-C) Features
Figure 4. Opioid-Induced Constipation (OIC) Features
Figure 5. Global Constipation Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Constipation Report Years Considered
Figure 10. Global Constipation Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Constipation Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Constipation Market Share by Regions: 2020 VS 2027
Figure 13. Global Constipation Market Share by Regions (2022-2027)
Figure 14. Global Constipation Market Share by Players in 2020
Figure 15. Global Top Constipation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Constipation as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Constipation Revenue in 2020
Figure 17. Global Constipation Revenue Market Share by Type (2016-2021)
Figure 18. Global Constipation Revenue Market Share by Type (2022-2027)
Figure 19. North America Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Constipation Market Share by Type (2016-2027)
Figure 21. North America Constipation Market Share by Application (2016-2027)
Figure 22. North America Constipation Market Share by Country (2016-2027)
Figure 23. United States Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Constipation Market Share by Type (2016-2027)
Figure 27. Europe Constipation Market Share by Application (2016-2027)
Figure 28. Europe Constipation Market Share by Country (2016-2027)
Figure 29. Germany Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Constipation Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Constipation Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Constipation Market Share by Region (2016-2027)
Figure 39. China Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Constipation Market Share by Type (2016-2027)
Figure 47. Latin America Constipation Market Share by Application (2016-2027)
Figure 48. Latin America Constipation Market Share by Country (2016-2027)
Figure 49. Mexico Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Constipation Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Constipation Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Constipation Market Share by Country (2016-2027)
Figure 55. Turkey Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Constipation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Takeda Pharmaceutical Revenue Growth Rate in Constipation Business (2016-2021)
Figure 59. Synergy Pharmaceuticals Revenue Growth Rate in Constipation Business (2016-2021)
Figure 60. Sucampo Pharmaceuticals Revenue Growth Rate in Constipation Business (2016-2021)
Figure 61. Ironwood Pharmaceuticals Revenue Growth Rate in Constipation Business (2016-2021)
Figure 62. Bausch Health Revenue Growth Rate in Constipation Business (2016-2021)
Figure 63. Abbott Revenue Growth Rate in Constipation Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Constipation Business (2016-2021)
Figure 65. Cosmo Pharmaceuticals Revenue Growth Rate in Constipation Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Constipation Business (2016-2021)
Figure 67. Daewoong Pharmaceuticals Revenue Growth Rate in Constipation Business (2016-2021)
Figure 68. Bayer Revenue Growth Rate in Constipation Business (2016-2021)
Figure 69. Prestige Brands Holdings Revenue Growth Rate in Constipation Business (2016-2021)
Figure 70. Janssen Pharmaceutical Revenue Growth Rate in Constipation Business (2016-2021)
Figure 71. Shionogi Revenue Growth Rate in Constipation Business (2016-2021)
Figure 72. Albireo Pharma Revenue Growth Rate in Constipation Business (2016-2021)
Figure 73. Renexxion Revenue Growth Rate in Constipation Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界のオピオイド誘発性便秘治療市場規模・現状・予測（2021年-2027年） There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over …- 世界のオピオイド誘発性便秘（OIC）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Opioid-Induced Constipation (OIC) Treatment Market The global Opioid-Induced Constipation (OIC) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in …
- 世界の便秘市場規模・現状・予測（2021年-2027年） Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing …
- 世界のオピオイド誘発性便秘薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Opioid Induced Constipation Drugs Market The global Opioid Induced Constipation Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 世界のオピオイド誘発性便秘薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Opioid Induced Constipation Drugs Market The global Opioid Induced Constipation Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…